BPC-157 may also upregulate the expression of early growth response gene-1 (EGR-1), which is a growth factor with potential benefits for the nervous system, having been suggested to aid in early extracellular matrix (collagen) formation [5]
Clinical trial results for CagriSema showed significant improvements in A1C, weight loss, and time in range, marking it as a promising new type 2 diabetes and weight management treatment
Clinical research involving approximately 900 participants across six human trials specifically measured serum IGF-1 concentrations and found no changes with AOD-9604 treatment at doses up to 1 mg per day and beyond
Aging is associated with decreased activity of the ubiquitin proteasome system
"The 503A pathway is the first step of accountability, and I think that's really ultimately what we're looking for
The patient frustration lies in feeling controlled by a law that treats a life-sustaining nutrient as if it were a high-risk pharmaceutical, simply because of how it is delivered